Skip to main content
Erschienen in: BMC Dermatology 1/2016

Open Access 01.12.2016 | Research article

Patch testing in Iranian children with allergic contact dermatitis

verfasst von: Hossein Mortazavi, Amirhooshang Ehsani, Seyed Sajed Sajjadi, Nessa Aghazadeh, Ebrahim Arian

Erschienen in: BMC Dermatology | Ausgabe 1/2016

Abstract

Background

Allergic contact dermatitis is a common disorder in adults and children alike and appears to be on the increase. The purpose of this study was to determine the sensitization trends in Iranian children with contact dermatitis.

Methods

The result of 109 patch tests performed using the 24 allergens of the European Standard Series in patients below 18 years old from September 2007 to March 2009 were recorded and analyzed. The tests were evaluated at 48 and 72 h after performing.

Results

The study population consisted of 72 (66.1 %) females and 37 (33.9 %) males. Hands were the most commonly affected anatomic site. In the final evaluation of the tests on day three, 51 (46.8 %) individuals showed a positive reaction to at least one allergen. Females were significantly more likely to show a positive response to at least one allergen (p-value = 0.031, odds ratio: 2.46). The most common allergens were nickel sulfate, cobalt, methylisothiazolinone, and colophony with 21 (19.3 %), 11 (10.1 %), 7 (6.4 %), and 6 (5.5 %) positive reactions, respectively. Contact allergy to nickel sulfate was more common in females than males (23.6 % vs. 10.8 %). There was no statistically significant relationship between personal or family history of atopy and a positive reaction to patch testing. The clinical and practical relevance were assessed for nickel and cobalt with a clinical current relevance in 11 (52.3 %) and 4 (36.4 %), respectively.

Conclusions

Nickel sulfate, cobalt, methylisothiazolinone, and colophony are the most common allergens responsible for induction of allergic contact dermatitis in Iranian children and adolescents. Females tended to show more positive reactions to allergens.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​s12895-016-0047-0) contains supplementary material, which is available to authorized users.

Background

Allergic contact dermatitis (ACD) is an inflammatory skin disease caused by a T-cell-mediated delayed-type hypersensitivity reaction [1]. In ACD, the hapten is initially introduced to the epidermal langerhans cells. These cells migrate to the regional lymph nodes and the allergen is subsequently processed by the T-lymphocytes. Upon re-exposure of the allergen, CD8+ T-cells response is mediated by the CD4+ T-cell subset [2].
ACD affects up to 20 % of the pediatric population [3]. According to previous studies, 14.5 to 70.7 % of children with a clinical diagnosis of contact dermatitis have positive reactions to one of the applied allergens for patch testing [4, 5]. Based on a recent review of five patch test studies in children, the most commonly reported allergens in children are neomycin, balsam of Peru, fragrance mix, lanolin, cocamidopropylbetaine, formaldehyde, corticosteroids, methylchlorisothiazolinone/methylisothiazolinone, propylene glycol, and benzalkonium chloride [6]. Properly performed and interpreted patch testing is the gold standard for identification and documentation of allergic sensitization and its inducing agents in children and adults [7, 8]. Although patch testing in children is not approved by the FDA, it has proven to be a safe procedure both in adults and children [9]. There are no rules and limitations for patch testing in children in Iran. Therefore, we often use it on similar approved indication for adults.
The purpose of this study was to determine the causes of allergic contact dermatitis and identify the pattern of allergen responsiveness in Iranian children and adolescents affected by ACD.

Methods

The study was approved by Tehran University of Medical Scienced board of ethics. Registered data of 109 patch tests performed in individuals younger than 18 years old diagnosed clinically and/or histopathologically with allergic contact dermatitis and referred by dermatologists for patch testing were collected and analyzed. We used the ESS (European Standard Series Hermal, Reinbek, Germany) at similar allergen concentrations as for adults. The allergens were applied on the healthy skin of the patients’ backs and left for 48 h. Readings were performed at 48 h, 72 h and after patch testing (on day 2 and day 3). Reactions were classified and documented according to the criteria of the International Contact Dermatitis Research Group (ICDRG) as follows: (0 = negative), (+/− = doubtful), (+ = erythema), (++ = papule vesicle formation), and (+++ = bulla formation or ulceration) [7].

Statistical analysis

Data management and descriptive statistical analysis were performed using the SPSS 16 statistical program. Chi-square and Fisher’s exact tests were used and a P-value less than 0.05 was considered a statistically significant difference.

Results

The study population consisted of 37 (33.9 %) males and 72 (66.1 %) females. The mean age was 14.4 with a standard deviation of 3.4 years (range: 5–18 years). A positive personal history of atopy was recorded in 48 patients (44.0 %). Forty one (37.6 %) had a positive family history of atopy. Anatomic sites of involvement in order of frequency are shown in Table 1. Hands were the most common site of involvement (Additional files 1 and 2).
Table 1
Anatomic sites of involvement in order of frequency
Anatomic sites of involvement
Frequency
Hand
84 (77.1 %)
Face
30 (27.5 %)
Calf
23 (21.1 %)
Foot
17 (15.6 %)
Back
9 (8.2 %)
Forearm
9 (8.2 %)
Abdomen
8 (8.7 %)
Knee
7 (7.6 %)
Thorax
7 (7.6 %)
Arm
6 (6.5 %)
Body
6 (6.5 %)
Results of patch test reading on day 2 and re-evaluation on day 3 (72 h) with regard to one or more reaction to allergens or negative or doubtful results in male and female patients are shown in Table 2.
Table 2
The overall positive, doubtful and negative responses to patch test allergens among male and female patients
Gender
Positive
Percent
Negative
Percent
Doubtful
Percent
Male (N = 37)
12
32.4
12
32.4
13
35.2
Female (N = 72)
39
54.2
25
34.7
8
11.1
Total (N = 109)
51
46.8
37
33.9
21
19.3
Females were significantly more likely to show a positive response to at least one allergen (p-value = 0.031, odds ratio: 2.46, 95 %, and confidence interval (CI): 1.07–5.64). We found no significant difference in the frequency of positive patch test responses among patients with and without personal or family history of atopy (Table 3).
Table 3
Comparison of reactions to allergens (at least one positive or negative reaction) in patients with or without personal or family history of atopy
 
Total
Reaction to allergens
p-value
Positive (one or more reactions)
Negative
personal history of atopy
+
48
26 (54.2 %)
22 (45.8 %)
0.171
-
61
25 (41.0 %)
36 (59.0 %)
family history of atopy
+
41
23 (56.1 %)
18 (43.9 %)
0.130
-
68
28 (41.2 %)
40 (58.8 %)
The overall results of patch test reading on day 2 and re-evaluation on day 3 based on gender are shown in Table 4. The ten most common inciting allergen in our series were nickel sulfate (21,19.3 %), cobalt chloride (11,10.1 %), methylisothiazolinone (7,6.4 %), colophony (6,5.5 %), potassium dichromate (5,4.6 %), paraben mix (4,3.7 %), 4-tert-butylphenon (4,3.7 %), fragrance mix (4,3.7 %), thiuram mix (3,2.8 %), mercapto mix (3,2.8 %), 4-phenylendiamine base (2,1.8 %), and formaldehyde (2,1.8 %) (Additional file 2).
Table 4
Positive response to allergens of the European standard series in Iranian children with allergic contact dermatitis
Substance
Concentration (%)
Total (N = 109)
Percent
Male (N = 37)
Percent
Female (N = 72)
Percent
P-Value
Relevance
Nickel sulfate
5
21
19.3
4
10.8
17
23.6
0.130
11 (52.3 %)
Cobalt chloride
1
11
10.1
5
13.5
6
8.3
0.504
4 (36.4 %)
Methylisothiazolinone
0.05
7
6.4
1
2.7
6
8.3
0.419
NA
Colophony
20
6
5.5
1
2.7
5
6.9
0.662
NA
Potassium dichromate
0.5
5
4.6
3
8.1
2
2.8
0.334
NA
Paraben mix
16
4
3.7
2
5.4
2
2.8
0.603
NA
4-tert-butylphenol formaldehyde resin
1
4
3.7
0
0.0
4
5.6
0.297
NA
Fragrance mix
8
4
3.7
1
2.7
3
4.2
1.000
NA
Thiuram mix
1
3
2.8
1
2.7
2
2.8
1.000
NA
Mercapto mix
1
3
2.8
0
0.0
3
4.2
0.550
NA
4-Phenylenediamine base
1
2
1.8
0
0.0
2
2.8
0.547
NA
Formaldehyde
1
2
1.8
1
2.7
1
1.4
1.000
NA
N-isopropyl-N-phenyl-4-phenylenediamine
0.1
2
1.8
1
2.7
1
1.4
1.000
NA
Wool Alcohol
30
2
1.8
0
0.0
2
2.8
0.547
NA
Sesquiterpene lactone mix
0.1
2
1.8
2
5.4
0
0.0
0.113
NA
Benzocaine
5
2
1.8
0
0.0
2
2.8
0.547
NA
Cliquinol
5
1
0.9
1
2.7
0
0.0
0.339
NA
Balsam of peru
25
1
0.9
0
0.0
1
1.4
1.000
NA
Epoxy resin
1
1
0.9
0
0.0
1
1.4
1.000
NA
Quaterium-15
1
1
0.9
0
0.0
1
1.4
1.000
NA
Mercaptobenzothiazole
2
1
0.9
1
2.7
0
0.0
0.339
NA
Neomycin sulphate
20
1
0.9
0
0.0
1
1.4
1.000
NA
Hydroxyl-methyl-penthyl-cyclo-carboxaldehyde
5
1
0.9
1
2.7
0
0.0
0.339
NA
Primin
0.01
0
0.0
0
0.0
0
0.0
NA
NA
Positive allergic reaction to nickel was more common in females than in males, however, without statistical significance (23.6 % vs. 10.8 %, p-value = 0.130) (Table 4).
We could only assess the clinical and practical relevance in the two most important allergens (nickel and cobalt), and we observed clinical current relevance in 11 (52.3 %) and 4 (36.4 %) for nickel and cobalt, respectively.
Results of patch test reading according to age groups are shown in Table 5.
Table 5
The positive patch test responses according to the inciting allergen and age group (0–10, 11–8 years)
Substance
0–10 (N = 22)
Percent
11–18 (N = 87)
Percent
P-Value
Nickel sulfate
3
13.6
18
20.7
0.55
Cobalt chloride
4
18.2
7
8.0
0.22
Methylisothiazolinone
2
9.1
5
5.7
0.62
Colophony
1
4.5
5
5.7
1.0
Potassium dichromate
0
0.0
5
5.7
0.58
Paraben mix
2
9.1
2
2.3
0.17
4-tert-butylphenon
0
0.0
4
4.6
0.58
Fragrance mix
1
4.5
3
3.4
1.0
Thiuram mix
0
0.0
3
3.4
1.0
Mercapto mix
0
0.0
3
3.4
1.0
Phenylendiamine base
0
0.0
2
2.3
1.0
Formaldehyde
0
0.0
2
2.3
1.0
N-isopropyl-N-phenyl-4-phenylenediamine
0
0.0
2
2.3
1.0
Wool Alcohol
0
0.0
2
2.3
1.0
Sesquiterpene lactone mix
0
0.0
2
2.3
1.0
Benzocaine
0
0.0
2
2.3
1.0
Cliquinol
0
0.0
1
1.1
1.0
Balsam of peru
0
0.0
1
1.1
1.0
Epoxy resin
0
0.0
1
1.1
1.0
Quaterium-18
0
0.0
1
1.1
1.0
Mercaptobenzothiazole
0
0.0
1
1.1
1.0
Neomycin sulphate
0
0.0
1
1.1
1.0
Hydroxyl-methyl-penthyl-cyclo-carboxaldehyde
0
0.0
1
1.1
1.0
Primin
0
0.0
0
0.0
NA
For most allergens (except cobalt chloride, methylisothiazolinone, paraben mix, and fragrance mix), the percentages of positive response in the older age group (11–18 years) were higher than children below 10 years.
The most common allergen in the younger age group were cobalt chloride (4, 18.2 %), nickel sulfate (3, 13.6 %), methylisothiazolinone (2, 9.1 %), and paraben mix (2, 9.1 %) while in the older group they were as follows: nickel sulfate, cobalt chloride, methylisothiazolinone, colophony, potassium dichromate.

Discussion

In this study we have identified the inciting allergen according to patch tests in 109 children with ACD. Contact dermatitis in children has been studied less extensively than adults in the existing literature [10, 11].
In the current study, overall 48.6 % of patients had one or more positive patch test results. The positive response rate to patch test allergens ranges from 15 to 62.3 % in different studies [5, 12, 13].
Nickel was the most common allergen in our study, a common finding with most previous reports [10, 14, 15]. Although some authors have reported the rate of false-positive and irritant reactions to nickel is higher among children [16], other studies suggest that this high rate might be due to use of adult concentration of allergen for patch testing [17], and the recent series do not confirm this [6]. We could not demonstrate clinical relevance in about half of the cases in our study. In our series nickel sulfate, cobalt chloride, methylisothiazolinone, colophony, potassium dichromate, paraben mix, 4-tert-butylphenon, fragrance mix, thiuram mix, mercapto mix, phenylendiamine base, and formaldehyde were the most common allergens in decreasing order of frequency.
The most commonly reported allergens in a study in Singapore were Nickel (40 %), Thimerosal (15 %), Colophony (9 %), Lanolin (8 %), Cobalt (8 %), Fragrance mix (5 %), and Neomycin (4 %) [18]. While in another study in Turkey, the most commonly documented inciting allergens were Nickel sulfate (46 %), Cobalt chloride (9.5 %), p-Phenylenediamine (9.5 %), Neomycin sulfate 20 % (7 %), Formaldehyde 1 % (4.6 %), Fragrance mix 8 % (3.9 %), CL-methylisothiazolinone 0.01 % (3.1 %), Mercapto mix 2 % (3.1 %), Quaternium 15 % (2.3 %), Benzocaine 5 % (2.3 %), and Potassium dichromate 0.5 % (1.5 %) [19]. In a recent review of five pediatric patch test studies to, the top ten allergens were neomycin, balsam of Peru, fragrance mix, lanolin, cocamidopropylbetaine, formaldehyde, corticosteroids, methylchlorisothiazolinone/methylisothiazolinone, propylene glycol, and benzalkonium chloride [6]. The observed differences in the frequency of the allergens responsible for induction of ACD between the present study and other studies may be explained by a variety of reasons. First and foremost, the prevalence of sensitivity to an individual allergen depends not only on the intrinsic allergenicity of the compound but also on the level of allergen exposure to the population, which may vary from country to country [2023]. Another important issue is that investigators often employ a variety of test panels and allergen concentrations in different studies, therefore rendering comparisons difficult [23]. There are disagreements as to whether there is seasonal and temporal variation in reactivity to allergens [24]. Moreover, reactivity to some allergens may be influenced by ethnic factors [25].
Gender differences in rates of reactions to a variety of contact allergens have been previously reported [2, 5]. In our study females were significantly more likely to have positive tests. This finding is consistent with previously published studies [5, 12, 15]. Nevertheless, in one study no difference between sex and reactivity to the applied allergens was observed [26].
In the current study, nickel sensitivity was also found to be more frequent in females; however, without statistical significance (Table 4). Ear piercing has been considered as the most common cause of nickel sensitization and the reason for its higher rate in females, with the risk of nickel allergy rising with the number of piercings [12]. Piercing is a common tradition in Iran and is usually performed in girls early in life often followed by long term wearing of golden earing to keep the hole open. Low-carat gold may contain nickel [19] In contrast to studies reporting more potassium dichromate reactivity in adult males, we found no male predominance for this allergen [27, 28].
As previously reported, co-reactivity between cobalt and nickel allergy was observed in our study [2, 18]. We found that in 45.5 % of patients with positive cobalt responses nickel reactivity was also present, while 23.8 % of patients with positive patch tests to nickel also had positive reaction to cobalt. In agreement with our results, Rystedt reported that nickel sensitivity predisposed the patients to cobalt sensitivity [29].
Our results showed that older children tend to show more positive reactions to allergens. This finding is in concordance with a pervious study that showed the rate of patch test positivity was higher in older age groups [12]. Moreover, it should be taken into account that contact dermatitis increases with age and is more common in older individuals [30]. However, according to some researchers an age-dependent decrease in delayed type hypersensitivity may occur with age [30].
In the present study 44.0 % of patients had a personal history of atopy. The relationship between atopy and ACD remains controversial [31, 32]. Although it has been assumed that atopy could be a predisposing factor for the development of ACD, and more reactivity to specific allergens have been reported in atopic patient [3335]; we found no significant association between personal or family history of atopy and patch test results. In concordance with our findings, some studies indicate that there is a similar prevalence of ACD in individuals with and without atopic diathesis [31, 36]. Hands were the most frequent sites of ACD in our study. Metal preservative and rubber are the most common causes for ACD of this region [11]. Also, in our study metal was the most common causative allergens of ACD.
In the present study, the face was the second most frequent ACD anatomic site. In some studies, the face was the most common site of ACD in children and adolescents [11].
Positive clinical relevance of the positive reactions was considered if the patient described a current or past cutaneous exposure to a product known to contain the allergen to which the patient reacted [7]. For some allergens in the pediatric patient group evaluation of relevance was not possible due to unknown history of exposure.
Methylisothiazolinone is a common preservative found in many cosmetic and toiletry products marketed to both children and adults. It is increasingly known to cause ACD, especially in perioral and perineal regions due to facial or baby wipes [37]. Colophony is a cause of ACD to adhesives and tapes. However, the clinical relevance of a positive patch-test reaction to colophony is often difficult to evaluate [38].
Our study is limited by small sample size, also we were unable to evaluate the relevance for positive patch test for all antigens. Studies with greater sample size and with adequate antigen relevance determination is recommended in Iranian children with ACD.

Conclusion

Our results indicate that nickel sulfate, cobalt, methylisothiazolinone, and colophony are the most common allergens responsible for induction of allergic contact dermatitis in Iranian children and adolescents. Females tend to show more positive reactions to allergens. These findings are crucial in the treatment, long term management, and proper education of children with allergic contact dermatitis.

Abbreviation

ACD, allergic contact dermatitis

Acknowledgements

None.

Funding

None.

Availability of data and materials

The datasets supporting the conclusions of this article are included within the article and its additional files.

Authors’ contributions

HM participated in the design, analysis and interpretation of data. SSS collected the data and did the statistical analysis. NA interpreted the data and drafted the manuscript. AH critically revised the manuscript and helped in the coordination and data analysis. All authors have read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.
The study was approved by the Tehran University of Medical Sciences Board of Ethics (code: 20869). Name of the ethics committee present: Dr Ali Jafarian, Dr Masoud Younesian, Mommad Rahim Ghohestani, Dr Nikzar Isazadeh, Dr Akbar Fotouhi, Dr Alirza Parsapour, Dr Mohammad Marandi, Dr Fariba Asghari.
The manuscript has not been published and is not currently under consideration for publication elsewhere. An abstract of this paper was presented as poster to the 29th Congress of the European Academy of Allergy and Clinical Immunology, London, June, 2010.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Rich RR, Fleisher TA, Shearer WT, Schroeder Jr HW, Frew AJ, Weyand CM. Clinical Immunology, Principles and Practice. 4th ed. China: Elsevier Health Sciences; 2013. Rich RR, Fleisher TA, Shearer WT, Schroeder Jr HW, Frew AJ, Weyand CM. Clinical Immunology, Principles and Practice. 4th ed. China: Elsevier Health Sciences; 2013.
2.
Zurück zum Zitat Rietschel RL, Fowler JF, Fisher AA. Fisher’s contact dermatitis. 6th ed. Hamilton: BC Decker Inc.; 2008. Rietschel RL, Fowler JF, Fisher AA. Fisher’s contact dermatitis. 6th ed. Hamilton: BC Decker Inc.; 2008.
3.
Zurück zum Zitat Militello G, Jacob SE, Crawford GH. Allergic contact dermatitis in children. Curr Opin Pediatr. 2006;18(4):385–90.CrossRefPubMed Militello G, Jacob SE, Crawford GH. Allergic contact dermatitis in children. Curr Opin Pediatr. 2006;18(4):385–90.CrossRefPubMed
4.
Zurück zum Zitat Zug KA, McGinley-Smith D, Warshaw EM, Taylor JS, Rietschel RL, Maibach HI, Belsito DV, Fowler JF, Storrs FJ, DeLeo VA. Contact allergy in children referred for patch testing: North American Contact Dermatitis Group data, 2001–2004. Arch Dermatol. 2008;144(10):1329–36.CrossRefPubMed Zug KA, McGinley-Smith D, Warshaw EM, Taylor JS, Rietschel RL, Maibach HI, Belsito DV, Fowler JF, Storrs FJ, DeLeo VA. Contact allergy in children referred for patch testing: North American Contact Dermatitis Group data, 2001–2004. Arch Dermatol. 2008;144(10):1329–36.CrossRefPubMed
5.
Zurück zum Zitat Mortz CG, Andersen KE. Allergic contact dermatitis in children and adolescents. Contact Dermatitis. 1999;41(3):121–30.CrossRefPubMed Mortz CG, Andersen KE. Allergic contact dermatitis in children and adolescents. Contact Dermatitis. 1999;41(3):121–30.CrossRefPubMed
6.
Zurück zum Zitat Hill H, Goldenberg A, Golkar L, Beck K, Williams J, Jacob SE. Pre-Emptive Avoidance Strategy (P.E.A.S.) - addressing allergic contact dermatitis in pediatric populations. Expert Rev Clin Immunol. 2016;12(5):551–61.CrossRefPubMed Hill H, Goldenberg A, Golkar L, Beck K, Williams J, Jacob SE. Pre-Emptive Avoidance Strategy (P.E.A.S.) - addressing allergic contact dermatitis in pediatric populations. Expert Rev Clin Immunol. 2016;12(5):551–61.CrossRefPubMed
7.
Zurück zum Zitat Lachapelle J-M, Maibach HI. Patch Testing and Prick Testing: A Practical Guide Official Publication of the ICDRG, third edn. Heidelberg: Springer-Verlag Berlin Heidelberg; 2012. Lachapelle J-M, Maibach HI. Patch Testing and Prick Testing: A Practical Guide Official Publication of the ICDRG, third edn. Heidelberg: Springer-Verlag Berlin Heidelberg; 2012.
8.
Zurück zum Zitat Goldenberg A, Silverberg N, Silverberg JI, Treat J, Jacob SE. Pediatric allergic contact dermatitis: lessons for better care. J Allergy Clin Immunol Pract. 2015;3(5):661–7.CrossRefPubMed Goldenberg A, Silverberg N, Silverberg JI, Treat J, Jacob SE. Pediatric allergic contact dermatitis: lessons for better care. J Allergy Clin Immunol Pract. 2015;3(5):661–7.CrossRefPubMed
9.
Zurück zum Zitat Johansen JD, Aalto‐Korte K, Agner T, Andersen KE, Bircher A, Bruze M, Cannavó A, Giménez‐Arnau A, Gonçalo M, Goossens A. European Society of Contact Dermatitis guideline for diagnostic patch testing–recommendations on best practice. Contact Dermatitis. 2015;73(4):195–221.CrossRefPubMed Johansen JD, Aalto‐Korte K, Agner T, Andersen KE, Bircher A, Bruze M, Cannavó A, Giménez‐Arnau A, Gonçalo M, Goossens A. European Society of Contact Dermatitis guideline for diagnostic patch testing–recommendations on best practice. Contact Dermatitis. 2015;73(4):195–221.CrossRefPubMed
10.
Zurück zum Zitat Simonsen AB, Deleuran M, Johansen JD, Sommerlund M. Contact allergy and allergic contact dermatitis in children–a review of current data. Contact Dermatitis. 2011;65(5):254–65.CrossRefPubMed Simonsen AB, Deleuran M, Johansen JD, Sommerlund M. Contact allergy and allergic contact dermatitis in children–a review of current data. Contact Dermatitis. 2011;65(5):254–65.CrossRefPubMed
11.
Zurück zum Zitat Brod BA, Treat JR, Rothe MJ, Jacob SE. Allergic contact dermatitis: Kids are not just little people. Clin Dermatol. 2015;33(6):605–12.CrossRefPubMed Brod BA, Treat JR, Rothe MJ, Jacob SE. Allergic contact dermatitis: Kids are not just little people. Clin Dermatol. 2015;33(6):605–12.CrossRefPubMed
12.
Zurück zum Zitat Clayton T, Wilkinson S, Rawcliffe C, Pollock B, Clark S. Allergic contact dermatitis in children: should pattern of dermatitis determine referral? A retrospective study of 500 children tested between 1995 and 2004 in one UK centre. Br J Dermatol. 2006;154(1):114–7.CrossRefPubMed Clayton T, Wilkinson S, Rawcliffe C, Pollock B, Clark S. Allergic contact dermatitis in children: should pattern of dermatitis determine referral? A retrospective study of 500 children tested between 1995 and 2004 in one UK centre. Br J Dermatol. 2006;154(1):114–7.CrossRefPubMed
13.
Zurück zum Zitat Zug KA, Pham AK, Belsito DV, DeKoven JG, DeLeo VA, Fowler Jr JF, Fransway AF, Maibach HI, Marks Jr JG, Mathias CT. Patch testing in children from 2005 to 2012: results from the North American contact dermatitis group. Dermatitis. 2014;25(6):345–55.CrossRefPubMed Zug KA, Pham AK, Belsito DV, DeKoven JG, DeLeo VA, Fowler Jr JF, Fransway AF, Maibach HI, Marks Jr JG, Mathias CT. Patch testing in children from 2005 to 2012: results from the North American contact dermatitis group. Dermatitis. 2014;25(6):345–55.CrossRefPubMed
14.
Zurück zum Zitat Tuchman M, Silverberg JI, Jacob SE, Silverberg N. Nickel contact dermatitis in children. Clin Dermatol. 2015;33(3):320–6.CrossRefPubMed Tuchman M, Silverberg JI, Jacob SE, Silverberg N. Nickel contact dermatitis in children. Clin Dermatol. 2015;33(3):320–6.CrossRefPubMed
15.
Zurück zum Zitat Sharma VK, Asati DP. Pediatric contact dermatitis. Indian J Dermatol Venereol Leprol. 2010;76(5):514.CrossRefPubMed Sharma VK, Asati DP. Pediatric contact dermatitis. Indian J Dermatol Venereol Leprol. 2010;76(5):514.CrossRefPubMed
16.
Zurück zum Zitat Shah M, Lewis FM, Gawkrodger DJ. Patch testing in children and adolescents: five years’ experience and follow-up. J Am Acad Dermatol. 1997;37(6):964–8.CrossRefPubMed Shah M, Lewis FM, Gawkrodger DJ. Patch testing in children and adolescents: five years’ experience and follow-up. J Am Acad Dermatol. 1997;37(6):964–8.CrossRefPubMed
17.
Zurück zum Zitat Roul S, Ducombs G, Taieb A. Usefulness of the European standard series for patch testing in children. A 3-year single-centre study of 337 patients. Contact Dermatitis. 1999;40(5):232–5.CrossRefPubMed Roul S, Ducombs G, Taieb A. Usefulness of the European standard series for patch testing in children. A 3-year single-centre study of 337 patients. Contact Dermatitis. 1999;40(5):232–5.CrossRefPubMed
18.
Zurück zum Zitat Goon ATJ, Goh CL. Patch testing of Singapore children and adolescents: our experience over 18 years. Pediatr Dermatol. 2006;23(2):117–20.CrossRefPubMed Goon ATJ, Goh CL. Patch testing of Singapore children and adolescents: our experience over 18 years. Pediatr Dermatol. 2006;23(2):117–20.CrossRefPubMed
19.
Zurück zum Zitat Onder M, Adisen E. Patch test results in a Turkish paediatric population. Contact Dermatitis. 2008;58(1):63–5.CrossRefPubMed Onder M, Adisen E. Patch test results in a Turkish paediatric population. Contact Dermatitis. 2008;58(1):63–5.CrossRefPubMed
20.
Zurück zum Zitat Schnuch A, Geier J, Uter W. National rates and regional differences in sensitization to allergens of the standard series. Population-adjusted frequencies of sensitization (PAFS) in 40,000 patients from a multicenter study (IVDK). Occup Health Ind Med. 1998;2(38):83. Schnuch A, Geier J, Uter W. National rates and regional differences in sensitization to allergens of the standard series. Population-adjusted frequencies of sensitization (PAFS) in 40,000 patients from a multicenter study (IVDK). Occup Health Ind Med. 1998;2(38):83.
21.
Zurück zum Zitat Uter W, Hegewald J, Aberer W, Ayala F, Bircher A, Brasch J, Coenraads PJ, Schuttelaar ML, Elsner P, Fartasch M. The European standard series in 9 European countries, 2002/2003–first results of the European Surveillance System on Contact Allergies. Contact Dermatitis. 2005;53(3):136–45.CrossRefPubMed Uter W, Hegewald J, Aberer W, Ayala F, Bircher A, Brasch J, Coenraads PJ, Schuttelaar ML, Elsner P, Fartasch M. The European standard series in 9 European countries, 2002/2003–first results of the European Surveillance System on Contact Allergies. Contact Dermatitis. 2005;53(3):136–45.CrossRefPubMed
22.
Zurück zum Zitat Weston WL, Weston JA. Allergic contact dermatitis in children. Am J Dis Child. 1984;138(10):932–6.PubMed Weston WL, Weston JA. Allergic contact dermatitis in children. Am J Dis Child. 1984;138(10):932–6.PubMed
23.
Zurück zum Zitat Thompson TR, Belsito DV. Regional variation in prevalence and etiology of allergic contact dermatitis. Dermatitis. 2002;13(4):177–82.CrossRef Thompson TR, Belsito DV. Regional variation in prevalence and etiology of allergic contact dermatitis. Dermatitis. 2002;13(4):177–82.CrossRef
24.
Zurück zum Zitat Kränke B, Aberer W. Seasonal influence on patch test results in central Europe. Contact Dermatitis. 1996;34(3):215–31.CrossRefPubMed Kränke B, Aberer W. Seasonal influence on patch test results in central Europe. Contact Dermatitis. 1996;34(3):215–31.CrossRefPubMed
25.
Zurück zum Zitat DeLeo VA, Taylor SC, Belsito DV, Fowler JF, Fransway AF, Maibach HI, Marks JG, Mathias CT, Nethercott JR, Pratt MD. The effect of race and ethnicity on patch test results. J Am Acad Dermatol. 2002;46(2):S107–12.CrossRefPubMed DeLeo VA, Taylor SC, Belsito DV, Fowler JF, Fransway AF, Maibach HI, Marks JG, Mathias CT, Nethercott JR, Pratt MD. The effect of race and ethnicity on patch test results. J Am Acad Dermatol. 2002;46(2):S107–12.CrossRefPubMed
26.
Zurück zum Zitat Seidenari S, Giusti F, Pepe P, Mantovani L. Contact Sensitization in 1094 Children Undergoing Patch Testing over a 7‐Year Period. Pediatr Dermatol. 2005;22(1):1–5.CrossRefPubMed Seidenari S, Giusti F, Pepe P, Mantovani L. Contact Sensitization in 1094 Children Undergoing Patch Testing over a 7‐Year Period. Pediatr Dermatol. 2005;22(1):1–5.CrossRefPubMed
27.
Zurück zum Zitat Freireich‐Astman M, David M, Trattner A. Standard patch test results in patients with contact dermatitis in Israel: age and sex differences. Contact Dermatitis. 2007;56(2):103–7.CrossRefPubMed Freireich‐Astman M, David M, Trattner A. Standard patch test results in patients with contact dermatitis in Israel: age and sex differences. Contact Dermatitis. 2007;56(2):103–7.CrossRefPubMed
28.
Zurück zum Zitat Greig JE, Carson CF, Stuckey MS, Riley TV. Prevalence of delayed hypersensitivity to the European standard series in a self‐selected population. Australas J Dermatol. 2000;41(2):86–9.CrossRefPubMed Greig JE, Carson CF, Stuckey MS, Riley TV. Prevalence of delayed hypersensitivity to the European standard series in a self‐selected population. Australas J Dermatol. 2000;41(2):86–9.CrossRefPubMed
29.
Zurück zum Zitat Rystedt I, Fischer T. Relationship between nickel and cobalt sensitization in hard metal workers. Contact Dermatitis. 1983;9(3):195–200.CrossRefPubMed Rystedt I, Fischer T. Relationship between nickel and cobalt sensitization in hard metal workers. Contact Dermatitis. 1983;9(3):195–200.CrossRefPubMed
30.
Zurück zum Zitat Kwangsukstith C, Maibach HI. Effect of age and sex on the induction and elicitation of allergic contact dermatitis. Contact Dermatitis. 1995;33(5):289–98.CrossRefPubMed Kwangsukstith C, Maibach HI. Effect of age and sex on the induction and elicitation of allergic contact dermatitis. Contact Dermatitis. 1995;33(5):289–98.CrossRefPubMed
31.
Zurück zum Zitat Akhavan A, Cohen SR. The relationship between atopic dermatitis and contact dermatitis. Clin Dermatol. 2003;21(2):158–62.CrossRefPubMed Akhavan A, Cohen SR. The relationship between atopic dermatitis and contact dermatitis. Clin Dermatol. 2003;21(2):158–62.CrossRefPubMed
32.
Zurück zum Zitat Vender R. The utility of patch testing children with atopic dermatitis. Skin Therapy Lett. 2002;7(6):4–6.PubMed Vender R. The utility of patch testing children with atopic dermatitis. Skin Therapy Lett. 2002;7(6):4–6.PubMed
33.
Zurück zum Zitat Malajian D, Belsito DV. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis. J Am Acad Dermatol. 2013;69(2):232–7.CrossRefPubMed Malajian D, Belsito DV. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis. J Am Acad Dermatol. 2013;69(2):232–7.CrossRefPubMed
34.
Zurück zum Zitat Shaughnessy CN, Malajian D, Belsito DV. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis: reactivity to topical preservatives. J Am Acad Dermatol. 2014;70(1):102–7.CrossRefPubMed Shaughnessy CN, Malajian D, Belsito DV. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis: reactivity to topical preservatives. J Am Acad Dermatol. 2014;70(1):102–7.CrossRefPubMed
35.
Zurück zum Zitat Shaughnessy CN, Malajian D, Belsito DV. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis: Reactivity to surfactants. J Am Acad Dermatol. 2014;70(4):704–8.CrossRefPubMed Shaughnessy CN, Malajian D, Belsito DV. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis: Reactivity to surfactants. J Am Acad Dermatol. 2014;70(4):704–8.CrossRefPubMed
36.
Zurück zum Zitat Landeck L, Schalock P, Baden L, González E. Contact sensitization pattern in 172 atopic subjects. Int J Dermatol. 2011;50(7):806–10.CrossRefPubMed Landeck L, Schalock P, Baden L, González E. Contact sensitization pattern in 172 atopic subjects. Int J Dermatol. 2011;50(7):806–10.CrossRefPubMed
37.
Zurück zum Zitat Schlichte MJ, Katta R. Methylisothiazolinone: an emergent allergen in common pediatric skin care products. Dermatol Res Pract. 2014;2014:132564.PubMedPubMedCentral Schlichte MJ, Katta R. Methylisothiazolinone: an emergent allergen in common pediatric skin care products. Dermatol Res Pract. 2014;2014:132564.PubMedPubMedCentral
38.
Zurück zum Zitat Färm G. Contact allergy to colophony. Clinical and experimental studies with emphasis on clinical relevance. Acta Derm Venereol Suppl. 1997;201:1–42. Färm G. Contact allergy to colophony. Clinical and experimental studies with emphasis on clinical relevance. Acta Derm Venereol Suppl. 1997;201:1–42.
Metadaten
Titel
Patch testing in Iranian children with allergic contact dermatitis
verfasst von
Hossein Mortazavi
Amirhooshang Ehsani
Seyed Sajed Sajjadi
Nessa Aghazadeh
Ebrahim Arian
Publikationsdatum
01.12.2016
Verlag
BioMed Central
Erschienen in
BMC Dermatology / Ausgabe 1/2016
Elektronische ISSN: 1471-5945
DOI
https://doi.org/10.1186/s12895-016-0047-0

Weitere Artikel der Ausgabe 1/2016

BMC Dermatology 1/2016 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.